Literature DB >> 16581822

Expression of human DEC-205 (CD205) multilectin receptor on leukocytes.

Masato Kato1, Kylie J McDonald, Seema Khan, Ian L Ross, Slavica Vuckovic, Ke Chen, David Munster, Kelli P A MacDonald, Derek N J Hart.   

Abstract

DEC-205 (CD205) belongs to the macrophage mannose receptor family of C-type lectin endocytic receptors and behaves as an antigen uptake/processing receptor for dendritic cells (DC). To investigate DEC-205 tissue distribution in human leukocytes, we generated a series of anti-human DEC-205 monoclonal antibodies (MMRI-5, 6 and 7), which recognized epitopes within the C-type lectin-like domains 1 and 2, and the MMRI-7 immunoprecipitated a single approximately 200 kDa band, identified as DEC-205 by mass spectrometry. MMRI-7 and another DEC-205 mAb (MG38), which recognized the epitope within the DEC-205 cysteine-rich and fibronectin type II domain, were used to examine DEC-205 expression by human leukocytes. Unlike mouse DEC-205, which is reported to have predominant expression on DC, human DEC-205 was detected by flow cytometry at relatively high levels on myeloid blood DC and monocytes, at moderate levels on B lymphocytes and at low levels on NK cells, plasmacytoid blood DC and T lymphocytes. MMRI-7 F(ab')2 also labeled monocytes, B lymphocytes and NK cells similarly excluding reactivity due to non-specific binding of the mAb to FcgammaR. Tonsil mononuclear cells showed a similar distribution of DEC-205 staining on the leukocytes. DEC-205-specific semiquantitative immunoprecipitation/western blot and quantitative reverse transcriptase-PCR analysis established that these leukocyte populations expressed DEC-205 protein and the cognate mRNA. Thus, human DEC-205 is expressed on more leukocyte populations than that were previously assumed based on mouse DEC-205 tissue localization studies. The broader DEC-205 tissue expression in man is relevant to clinical DC targeting strategies and DEC-205 functional studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581822     DOI: 10.1093/intimm/dxl022

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  56 in total

1.  Generation of anti-human DEC205/CD205 monoclonal antibodies that recognize epitopes conserved in different mammals.

Authors:  Chae Gyu Park; Anthony Rodriguez; Hisashi Ueta; Haekyung Lee; Maggi Pack; Kenjiro Matsuno; Ralph M Steinman
Journal:  J Immunol Methods       Date:  2012-01-16       Impact factor: 2.303

2.  Interleukin-6 receptor enhances early colonization of the murine omentum by upregulation of a mannose family receptor, LY75, in ovarian tumor cells.

Authors:  Premkumar Vummidi Giridhar; Holly M Funk; Catherine A Gallo; Aleksey Porollo; Carol A Mercer; David R Plas; Angela F Drew
Journal:  Clin Exp Metastasis       Date:  2011-09-02       Impact factor: 5.150

Review 3.  Advancing drug delivery systems for the treatment of multiple sclerosis.

Authors:  Inna Tabansky; Mark D Messina; Catherine Bangeranye; Jeffrey Goldstein; Karen M Blitz-Shabbir; Suly Machado; Venkatesh Jeganathan; Paul Wright; Souhel Najjar; Yonghao Cao; Warren Sands; Derin B Keskin; Joel N H Stern
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

4.  Antigen-conjugated human IgE induces antigen-specific T cell tolerance in a humanized mouse model.

Authors:  Günther Baravalle; Alexandra M Greer; Taylor N LaFlam; Jeoung-Sook Shin
Journal:  J Immunol       Date:  2014-03-07       Impact factor: 5.422

5.  The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury.

Authors:  Saravanakumar Selvaraj; Jung-Hwa Oh; Reinhard Spanel; Florian Länger; Hyoung-Yun Han; Eun-Hee Lee; Seokjoo Yoon; Jürgen Borlak
Journal:  Oncotarget       Date:  2017-09-23

6.  Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes.

Authors:  Jennifer Schloss; Riyasat Ali; Jeffrey Babad; Ignacio Guerrero-Ros; Jillamika Pongsachai; Li-Zhen He; Tibor Keler; Teresa P DiLorenzo
Journal:  Immunohorizons       Date:  2019-06-26

7.  Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition.

Authors:  Kirsteen M Tullett; Ingrid M Leal Rojas; Yoshihito Minoda; Peck S Tan; Jian-Guo Zhang; Corey Smith; Rajiv Khanna; Ken Shortman; Irina Caminschi; Mireille H Lahoud; Kristen J Radford
Journal:  JCI Insight       Date:  2016-05-19

8.  Comparative analysis of inflammatory infiltrates in collagen-induced arthritis, kidney graft rejection and delayed-type hypersensitivity in non-human primates.

Authors:  Margreet Jonker; Jacqueline Wubben; Krista Haanstra; Michel Vierboom; Bert 't Hart
Journal:  Inflamm Res       Date:  2012-10-13       Impact factor: 4.575

9.  Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host disease.

Authors:  Riyasat Ali; Jeffrey Babad; Antonia Follenzi; John A Gebe; Michael A Brehm; Gerald T Nepom; Leonard D Shultz; Dale L Greiner; Teresa P DiLorenzo
Journal:  Immunology       Date:  2016-08       Impact factor: 7.397

10.  Histoplasma capsulatum manifests preferential invasion of phagocytic subpopulations in murine lungs.

Authors:  George S Deepe; Reta S Gibbons; A George Smulian
Journal:  J Leukoc Biol       Date:  2008-06-24       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.